Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2013 Feb 28;33(5):1092–1097. doi: 10.1161/ATVBAHA.112.301089

Table 2.

Relative Risks (95% Confidence Intervals) of Lower Extremity Peripheral Artery Disease According to Total Adiponectin

Continuous Adiponectin
(per Each SD Increase in
ln-Transformed Variable)
Quartile of Adiponectin, Median (Range), μg/mL
2.84 (1.54-3.62) 4.28 (3.63-5.05) 5.98 (5.06-7.16) 9.02 (7.17-31.9) P trend
Cases, n 143 53 44 27 19
Controls, n 429 90 99 116 124
Matching variables 0.58 (0.47-0.72) 1.00 (Reference) 0.73 (0.45-1.19) 0.39 (0.23-0.66) 0.24 (0.13-0.44) <0.0001
Multivariable model 1 0.58 (0.45-0.74) 1.00 (Reference) 0.62 (0.35-1.10) 0.43 (0.24-0.79) 0.20 (0.10-0.42) <0.0001
Multivariable model 2 0.68 (0.51-0.92) 1.00 (Reference) 0.47 (0.24-0.91) 0.52 (0.27-1.00) 0.28 (0.12-0.67) 0.005
Multivariable model 3 0.68 (0.50-0.92) 1.00 (Reference) 0.48 (0.25-0.94) 0.55 (0.28-1.08) 0.28 (0.12-0.66) 0.006

Relative risks are derived from conditional logistic regression models. Matching variables were age, smoking status, fasting status and date of blood draw. Ptrend is calculated by treating the median of natural log-transformed adiponectin concentrations of each quartile as a continuous variable. Multivariable model 1 is adjusted for pack-years of smoking, history of type 2 diabetes, history of hypertension, history of hypercholesterolemia, parental history of myocardial infarction before age 60 y, body mass index and physical activity. Multivariable model 2 is model 1 + high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, C-reactive protein and cystatin C. Multivariable model 3 is model 2 + hemoglobin A1c, triglycerides and gamma-glutamyltransferase.